Oxaprozin
NDC Package 70332-310-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Oxaprozin is used to treat arthritis. Marketed by California Pharmaceuticals Llc, this product is identified by NDC 70332-310 and is authorized under FDA application ANDA075855.

Identification & Billing

NDC Package Code
70332-310-01
Package Description
14 TABLET, FILM COATED in 1 BOTTLE
Product Code
11-Digit Billing Format
70332031001
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
14 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Oxaprozin
Dosage Form
-
Usage Information
Oxaprozin is used to treat arthritis. It reduces pain, swelling, and stiffness of the joints. Oxaprozin is known as a nonsteroidal anti-inflammatory drug (NSAID). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section.

Regulatory & Marketing

Labeler Name
California Pharmaceuticals Llc
FDA Application #
ANDA075855
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-01-2017
Listing Expiration
12-31-2018
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70332-310). Click a package code to view its specific billing and regulatory data.

60 TABLET, FILM COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70332-310-01 identifies a specific commercial package of 14 tablet, film coated in 1 bottle of Oxaprozin, labeled by California Pharmaceuticals Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 14 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by California Pharmaceuticals Llc on July 01, 2017. The current certification is valid through December 31, 2018.

What are the primary indications for this medication?

Oxaprozin is used to treat arthritis. It reduces pain, swelling, and stiffness of the joints. Oxaprozin is known as a nonsteroidal anti-inflammatory drug (NSAID). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section.

How is this California Pharmaceuticals Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70332031001. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 14 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70332-310-01
11-Digit CMS (5-4-2)
70332-0310-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.